{"database": "lobbying", "table": "lobbying_activities", "rows": [[3801739, "5ad581d1-e060-4fd9-b402-66991b7a5e37", "Q1", "ELITE STRATEGIC SERVICES", 401108852, "CONSERVATIVES FOR PROPERTY RIGHTS", 2026, "first_quarter", "LBR", "H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act) S. 527 (Prescription Pricing for the People Act) Seeking ways to lower prescription drug prices by promoting competition without expropriating patent rights", "HOUSE OF REPRESENTATIVES,SENATE", 25000, null, 0, 0, "2026-04-01T15:25:31-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3801739"], "units": {}, "query_ms": 2.4908229243010283, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}